RecruitingNCT06566066

Register for Patients With Thyroid Hormone Resistance.

Studying Allan-Herndon-Dudley syndrome

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Charite University, Berlin, Germany
Principal Investigator: Heiko Krude, MD
Charite University, Berlin, Germany
Intervention: no intervention(other)
Enrollment: 200 enrolled
Eligibility: All sexes
Timeline: 2021 – 2029

Study locations (1)

Charite - Universitaetsmedizin Berlin, Berlin, Germany

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06566066 on ClinicalTrials.gov

Other trials for Allan-Herndon-Dudley syndrome

Additional recruiting or active studies for the same condition.

ACTIVE NOT RECRUITINGPHASE2NCT02396459
Triac Trial II in MCT8 Deficiency Patients
Rare Thyroid Therapeutics International AB

See all trials for Allan-Herndon-Dudley syndrome →

← Back to all trials